Literature DB >> 10513690

Methylphenidate effects on global and complex measures of EEG.

J F Lubar1, J N White, M O Swartwood, J N Swartwood.   

Abstract

Methylphenidate (MPH) effects on global and complex measures of electroencephalography were examined in boys with attention-deficit-hyperactivity disorder between the ages of 9 and 11 years. Electroencephalogram (EEG) data were collected separately from the administration of a continuous performance task and were evaluated for changes in overall frequency, coherence, phase, and asymmetry and against a referential database. MPH did not produce a clear change in EEG frequency measures compared with the task condition, although it did induce regional changes in the EEG and produced an improvement in task performance. In comparison against the referential database, MPH appeared to lessen the impact of abnormalities in EEG coherence, EEG phase, and EEG asymmetry on performance measures.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10513690     DOI： 10.1016/s0887-8994(99)00052-1

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  9 in total

1.  Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence.

Authors:  Michael Murias; James M Swanson; Ramesh Srinivasan
Journal:  Cereb Cortex       Date:  2006-10-05       Impact factor: 5.357

2.  Evaluation of the effect of methylphenidate by computed tomography, electroencephalography, neuropsychological tests, and clinical symptoms in children with attention-deficit/hyperactivity disorder: A prospective cohort study.

Authors:  Ozlem Yildiz Oc; Belma Agaoglu; Fatma Sen Berk; Sezer Komsuoglu; Isik Karakaya; Aysen Coskun
Journal:  Curr Ther Res Clin Exp       Date:  2007-11

3.  Objective versus subjective assessment of methylphenidate response.

Authors:  Iris Manor; Sheera Meidad; Gil Zalsman; Zvi Zemishlany; Sam Tyano; Abraham Weizman
Journal:  Child Psychiatry Hum Dev       Date:  2007-12-05

4.  Evaluation of Two Types of Drug Treatment with QEEG in Children with ADHD.

Authors:  Ramazan Aldemir; Esra Demirci; Ayşe Kaçar Bayram; Mehmet Canpolat; Sevgi Ozmen; Hüseyin Per; Mahmut Tokmakci
Journal:  Transl Neurosci       Date:  2018-09-01       Impact factor: 1.757

Review 5.  Treatment biomarkers for ADHD: Taking stock and moving forward.

Authors:  Giorgia Michelini; Luke J Norman; Philip Shaw; Sandra K Loo
Journal:  Transl Psychiatry       Date:  2022-10-12       Impact factor: 7.989

6.  Effects of methylphenidate on quantitative EEG of boys with attention-deficit hyperactivity disorder in continuous performance test.

Authors:  Dong Ho Song; Dong Won Shin; Duk In Jon; Eun Hye Ha
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

Review 7.  Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility.

Authors:  Guzmán Alba; Ernesto Pereda; Soledad Mañas; Leopoldo D Méndez; Almudena González; Julián J González
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-22       Impact factor: 2.570

8.  Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test.

Authors:  Geir Ogrim; Juri Kropotov; Jan Ferenc Brunner; Gian Candrian; Leiv Sandvik; Knut A Hestad
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-03       Impact factor: 2.570

9.  Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models.

Authors:  Tatsuya Yokota; Zbigniew R Struzik; Peter Jurica; Masahito Horiuchi; Shuichi Hiroyama; Junhua Li; Yuji Takahara; Koichi Ogawa; Kohei Nishitomi; Minoru Hasegawa; Andrzej Cichocki
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.